David N. Danforth

13.1k total citations · 2 hit papers
120 papers, 8.2k citations indexed

About

David N. Danforth is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, David N. Danforth has authored 120 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 40 papers in Cancer Research and 23 papers in Pathology and Forensic Medicine. Recurrent topics in David N. Danforth's work include Breast Cancer Treatment Studies (35 papers), Breast Lesions and Carcinomas (16 papers) and Estrogen and related hormone effects (9 papers). David N. Danforth is often cited by papers focused on Breast Cancer Treatment Studies (35 papers), Breast Lesions and Carcinomas (16 papers) and Estrogen and related hormone effects (9 papers). David N. Danforth collaborates with scholars based in United States, France and Canada. David N. Danforth's co-authors include Seth M. Steinberg, Marc E. Lippman, Eli Glatstein, Allen S. Lichter, Maria J. Merino, John C. Buckingham, Sandra M. Swain, Teresa D'Angelo, Alfred E. Chang and William F. Sindelar and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David N. Danforth

119 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

1998 1.1k citations Jin Yang, Alfred E. Chang et al. Journal of Clinical Oncology profile →
Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer

1995 683 citations David N. Danforth, Kenneth H. Cowan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David N. Danforth United States	43	3.1k	2.9k	1.9k	1.7k	1.4k	120	8.2k
Elizabeth H. Hammond United States	34	2.0k 0.6×	1.2k 0.4×	1.5k 0.8×	1.8k 1.0×	598 0.4×	95	6.8k
D. Wallwiener Germany	54	5.0k 1.6×	3.4k 1.2×	1.7k 0.9×	1.9k 1.1×	958 0.7×	608	12.8k
Jan‐Erik Damber Sweden	49	1.7k 0.5×	1.3k 0.4×	4.1k 2.2×	1.2k 0.7×	643 0.4×	261	8.6k
Thomas Krausz United States	60	3.4k 1.1×	1.3k 0.4×	4.2k 2.2×	2.1k 1.2×	1.1k 0.8×	222	13.4k
Neville F. Hacker Australia	59	2.6k 0.8×	974 0.3×	1.2k 0.6×	3.8k 2.2×	629 0.4×	246	11.4k
Gregory H. Reaman United States	68	3.6k 1.2×	1.1k 0.4×	2.1k 1.1×	893 0.5×	1.2k 0.8×	306	15.8k
Christof Sohn Germany	46	2.3k 0.7×	2.5k 0.9×	886 0.5×	975 0.6×	906 0.6×	303	7.7k
Laurence H. Baker United States	59	4.8k 1.6×	1.0k 0.4×	6.3k 3.4×	2.2k 1.3×	1.5k 1.0×	247	11.9k
Hugh Mulcahy Ireland	45	2.6k 0.8×	1.2k 0.4×	1.2k 0.6×	2.1k 1.2×	970 0.7×	204	6.9k
Ross S. Berkowitz United States	66	2.7k 0.9×	2.2k 0.8×	1.0k 0.5×	2.4k 1.4×	1.2k 0.8×	445	18.7k

Countries citing papers authored by David N. Danforth

Since Specialization

Citations

This map shows the geographic impact of David N. Danforth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Danforth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Danforth more than expected).

Fields of papers citing papers by David N. Danforth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Danforth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Danforth. The network helps show where David N. Danforth may publish in the future.

Co-authorship network of co-authors of David N. Danforth

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Danforth. A scholar is included among the top collaborators of David N. Danforth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Danforth. David N. Danforth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seitter, Samantha J., Richard M. Sherry, James Chih‐Hsin Yang, et al.. (2021). Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma. Clinical Cancer Research. 27(19). 5289–5298. 72 indexed citations

Danforth, David N., Armando Filie, Andrew Warner, et al.. (2020). Characteristics of Breast Ducts in Normal-Risk and High-risk Women and Their Relationship to Ductal Cytologic Atypia. Cancer Prevention Research. 13(12). 1027–1036. 3 indexed citations

Deniger, Drew C., Anna Pasetto, Paul F. Robbins, et al.. (2018). T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers. Clinical Cancer Research. 24(22). 5562–5573. 110 indexed citations

Chandran, Smita S., Robert Somerville, James C. Yang, et al.. (2017). Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study. The Lancet Oncology. 18(6). 792–802. 202 indexed citations

Danforth, David N.. (2013). Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Research. 15(3). 208–208. 98 indexed citations

Danforth, David N., Paul S. Albert, Linda Sciuto, et al.. (2005). Early ipsilateral breast tumor recurrences after breast conservation affect survival: An analysis of the National Cancer Institute randomized trial. International Journal of Radiation Oncology*Biology*Physics. 62(3). 785–789. 18 indexed citations

Wedam, Suparna, Jennifer A. Low, Xiao‐Sheng Yang, et al.. (2004). A pilot study to evaluate response and angiogenesis after treatment with bevacizumab in patients with inflammatory breast cancer. Journal of Clinical Oncology. 22(14_suppl). 578–578. 4 indexed citations

Danforth, David N., Kenneth H. Cowan, Rosemary M. Altemus, et al.. (2003). Preoperative FLAC/Granulocyte-Colony-Stimulating Factor Chemotherapy for Stage II Breast Cancer: A Prospective Randomized Trial. Annals of Surgical Oncology. 10(6). 635–44. 22 indexed citations

Yang, Jin, Alfred E. Chang, A Baker, et al.. (1998). Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.. Journal of Clinical Oncology. 16(1). 197–203. 1134 indexed citations breakdown →

10.

Jewesson, Peter J., Grant Stiver, Luciana Frighetto, et al.. (1996). Double-blind comparison of cefazolin and ceftizoxime for prophylaxis against infections following elective biliary tract surgery. Antimicrobial Agents and Chemotherapy. 40(1). 70–74. 14 indexed citations

11.

Danforth, David N. & Magda Sgagias. (1993). Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro.. PubMed. 53(7). 1538–45. 65 indexed citations

12.

Gerber, Lynn H., Mary Duncan, Teresa D'Angelo, et al.. (1992). Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation. Breast Cancer Research and Treatment. 21(2). 139–145. 97 indexed citations

13.

Lippman, Marc E., Allen S. Lichter, David N. Danforth, & Richard E. Wilson. (1989). Diagnosis in Management of Breast Cancer. Plastic & Reconstructive Surgery. 83(2). 383–383. 1 indexed citations

14.

Chang, Alfred E., Timothy J. Kinsella, Eli Glatstein, et al.. (1988). Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity.. Journal of Clinical Oncology. 6(9). 1491–1500. 145 indexed citations

15.

Lippman, M. E., et al.. (1986). Treatment of stage IIIA/B locally advanced breast cancer (LABC) with induction chemotherapy (CT) and hormonal synchronization (HS) followed by radiation therapy (RT) with or without mastectomy. International Journal of Radiation Oncology*Biology*Physics. 12. 152–152. 1 indexed citations

16.

Tamarkin, Lawrence, Osborne F. X. Almeida, & David N. Danforth. (1985). Melatonin and Malignant Disease. Novartis Foundation symposium. 117. 284–310. 12 indexed citations

17.

Danforth, David N., Arthur Veis, Moira Breen, et al.. (1974). The effect of pregnancy and labor on the human cervix: Changes in collagen, glycoproteins, and glycosaminoglycans. American Journal of Obstetrics and Gynecology. 120(5). 641–651. 187 indexed citations

18.

Danforth, David N.. (1966). Textbook of obstetrics and gynecology. 45 indexed citations

19.

McElin, Thomas W., David N. Danforth, & John C. Buckingham. (1959). Thrombophlebitis in antepartum patients. PubMed Central. 33(3). 242. 6 indexed citations

20.

Danforth, David N., et al.. (1956). ON THE STRENGTH OF THE FOETAL MEMBRANES. BJOG An International Journal of Obstetrics & Gynaecology. 63(2). 237–238. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact